Tosymra™ (sumatriptan) – New drug approval
January 28, 2019 - Dr. Reddy’s Laboratories and its subsidiary, Promius Pharma announced the FDA approval of Tosymra (sumatriptan) nasal spray, for the acute treatment of migraine with or without aura in adults.
Download PDF
